Cargando…
P047 Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, posaconazole, isuvuconazole, itraconazole against Rhizopus isolates of post COVID mucormycosis
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: To investigate and compare susceptibility pattern of Rhizopus isolates in post-COVID mucormycosis by disc diffusion (DD), E-test, and broth micro-dilution for amphotericin B, posaconazole. DD and BMD for isavuconazole and itraco...
Autores principales: | Gupta, Prashant, Hasan, Mohd Saqib |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509752/ http://dx.doi.org/10.1093/mmy/myac072.P047 |
Ejemplares similares
-
Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023) -
Successful treatment of pulmonary mucormycosis caused by Rhizopus microsporus with posaconazole
por: Yuan, F., et al.
Publicado: (2021) -
Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastoma
por: Athanasiadou, Kleoniki I., et al.
Publicado: (2019) -
Mitochondrial Respiratory Pathways Inhibition in Rhizopus oryzae Potentiates Activity of Posaconazole and Itraconazole via Apoptosis
por: Shirazi, Fazal, et al.
Publicado: (2013) -
P173 PK PD rationale and efficacy of isavuconazole treatment after failure of amphotericin B and posaconazole for COVID-19 associated cranial Mucormycosis
por: Soman, Rajeev, et al.
Publicado: (2022)